nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—UGT1A10—Valproic Acid—epilepsy syndrome	0.102	0.189	CbGbCtD
Etodolac—PTGS2—epilepsy syndrome	0.101	0.529	CbGaD
Etodolac—ALB—epilepsy syndrome	0.0902	0.471	CbGaD
Etodolac—UGT1A3—Lamotrigine—epilepsy syndrome	0.0656	0.121	CbGbCtD
Etodolac—UGT2B7—Carbamazepine—epilepsy syndrome	0.0408	0.0754	CbGbCtD
Etodolac—UGT1A9—Propofol—epilepsy syndrome	0.0361	0.0667	CbGbCtD
Etodolac—UGT1A3—Valproic Acid—epilepsy syndrome	0.0337	0.0623	CbGbCtD
Etodolac—UGT1A9—Valproic Acid—epilepsy syndrome	0.0258	0.0476	CbGbCtD
Etodolac—UGT2B7—Valproic Acid—epilepsy syndrome	0.0244	0.045	CbGbCtD
Etodolac—ALB—Oxcarbazepine—epilepsy syndrome	0.0213	0.0393	CbGbCtD
Etodolac—ALB—Fosphenytoin—epilepsy syndrome	0.0186	0.0344	CbGbCtD
Etodolac—ALB—Clonazepam—epilepsy syndrome	0.0168	0.0311	CbGbCtD
Etodolac—ALB—Rufinamide—epilepsy syndrome	0.0137	0.0254	CbGbCtD
Etodolac—PTGS1—Diazepam—epilepsy syndrome	0.0136	0.0251	CbGbCtD
Etodolac—SLC22A6—Acetazolamide—epilepsy syndrome	0.0126	0.0232	CbGbCtD
Etodolac—ALB—Phenytoin—epilepsy syndrome	0.012	0.0222	CbGbCtD
Etodolac—ALB—Propofol—epilepsy syndrome	0.0112	0.0207	CbGbCtD
Etodolac—PTGS1—Valproic Acid—epilepsy syndrome	0.0107	0.0198	CbGbCtD
Etodolac—CYP2C9—Trimethadione—epilepsy syndrome	0.0107	0.0197	CbGbCtD
Etodolac—ALB—Diazepam—epilepsy syndrome	0.0101	0.0187	CbGbCtD
Etodolac—CYP2C9—Fosphenytoin—epilepsy syndrome	0.01	0.0185	CbGbCtD
Etodolac—SLC22A6—Valproic Acid—epilepsy syndrome	0.00938	0.0173	CbGbCtD
Etodolac—CYP2C9—Carbamazepine—epilepsy syndrome	0.00721	0.0133	CbGbCtD
Etodolac—CYP2C9—Primidone—epilepsy syndrome	0.00673	0.0124	CbGbCtD
Etodolac—CYP2C9—Phenytoin—epilepsy syndrome	0.00647	0.0119	CbGbCtD
Etodolac—CYP2C9—Propofol—epilepsy syndrome	0.00603	0.0111	CbGbCtD
Etodolac—CYP2C9—Phenobarbital—epilepsy syndrome	0.00576	0.0106	CbGbCtD
Etodolac—CYP2C9—Diazepam—epilepsy syndrome	0.00546	0.0101	CbGbCtD
Etodolac—CYP2C9—Valproic Acid—epilepsy syndrome	0.00431	0.00796	CbGbCtD
Etodolac—RXRA—ganglion—epilepsy syndrome	0.00163	0.246	CbGeAlD
Etodolac—RXRA—forebrain—epilepsy syndrome	0.000683	0.103	CbGeAlD
Etodolac—RXRA—telencephalon—epilepsy syndrome	0.000628	0.0948	CbGeAlD
Etodolac—RXRA—head—epilepsy syndrome	0.000391	0.059	CbGeAlD
Etodolac—RXRA—nervous system—epilepsy syndrome	0.000371	0.056	CbGeAlD
Etodolac—PTGS1—ganglion—epilepsy syndrome	0.00036	0.0544	CbGeAlD
Etodolac—RXRA—central nervous system—epilepsy syndrome	0.000357	0.0539	CbGeAlD
Etodolac—RXRA—brain—epilepsy syndrome	0.000283	0.0428	CbGeAlD
Etodolac—SLC22A6—brain—epilepsy syndrome	0.000177	0.0266	CbGeAlD
Etodolac—PTGS1—forebrain—epilepsy syndrome	0.000151	0.0228	CbGeAlD
Etodolac—PTGS2—forebrain—epilepsy syndrome	0.000145	0.0218	CbGeAlD
Etodolac—PTGS1—telencephalon—epilepsy syndrome	0.000139	0.021	CbGeAlD
Etodolac—PTGS2—telencephalon—epilepsy syndrome	0.000133	0.0201	CbGeAlD
Etodolac—ALB—brain—epilepsy syndrome	0.00011	0.0166	CbGeAlD
Etodolac—PTGS2—medulla oblongata—epilepsy syndrome	0.000104	0.0158	CbGeAlD
Etodolac—PTGS1—spinal cord—epilepsy syndrome	9.74e-05	0.0147	CbGeAlD
Etodolac—PTGS2—midbrain—epilepsy syndrome	9.54e-05	0.0144	CbGeAlD
Etodolac—PTGS2—spinal cord—epilepsy syndrome	9.31e-05	0.014	CbGeAlD
Etodolac—PTGS1—head—epilepsy syndrome	8.66e-05	0.0131	CbGeAlD
Etodolac—PTGS2—head—epilepsy syndrome	8.28e-05	0.0125	CbGeAlD
Etodolac—PTGS1—nervous system—epilepsy syndrome	8.21e-05	0.0124	CbGeAlD
Etodolac—PTGS1—central nervous system—epilepsy syndrome	7.9e-05	0.0119	CbGeAlD
Etodolac—PTGS2—nervous system—epilepsy syndrome	7.85e-05	0.0118	CbGeAlD
Etodolac—PTGS2—central nervous system—epilepsy syndrome	7.55e-05	0.0114	CbGeAlD
Etodolac—PTGS2—cerebellum—epilepsy syndrome	7.38e-05	0.0111	CbGeAlD
Etodolac—PTGS1—brain—epilepsy syndrome	6.27e-05	0.00947	CbGeAlD
Etodolac—PTGS2—brain—epilepsy syndrome	6e-05	0.00905	CbGeAlD
Etodolac—Vomiting—Vigabatrin—epilepsy syndrome	4.6e-05	0.000242	CcSEcCtD
Etodolac—Hyperhidrosis—Valproic Acid—epilepsy syndrome	4.57e-05	0.000241	CcSEcCtD
Etodolac—Pruritus—Phenytoin—epilepsy syndrome	4.57e-05	0.000241	CcSEcCtD
Etodolac—Nausea—Levetiracetam—epilepsy syndrome	4.56e-05	0.000241	CcSEcCtD
Etodolac—Rash—Vigabatrin—epilepsy syndrome	4.56e-05	0.00024	CcSEcCtD
Etodolac—Dizziness—Felbamate—epilepsy syndrome	4.55e-05	0.00024	CcSEcCtD
Etodolac—Dermatitis—Vigabatrin—epilepsy syndrome	4.55e-05	0.00024	CcSEcCtD
Etodolac—Pruritus—Oxcarbazepine—epilepsy syndrome	4.54e-05	0.000239	CcSEcCtD
Etodolac—Convulsion—Pregabalin—epilepsy syndrome	4.54e-05	0.000239	CcSEcCtD
Etodolac—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.54e-05	0.000239	CcSEcCtD
Etodolac—Vision blurred—Gabapentin—epilepsy syndrome	4.53e-05	0.000239	CcSEcCtD
Etodolac—Headache—Vigabatrin—epilepsy syndrome	4.53e-05	0.000239	CcSEcCtD
Etodolac—Hypertension—Pregabalin—epilepsy syndrome	4.52e-05	0.000239	CcSEcCtD
Etodolac—Vomiting—Diazepam—epilepsy syndrome	4.52e-05	0.000238	CcSEcCtD
Etodolac—Anorexia—Valproic Acid—epilepsy syndrome	4.51e-05	0.000238	CcSEcCtD
Etodolac—Tremor—Gabapentin—epilepsy syndrome	4.5e-05	0.000237	CcSEcCtD
Etodolac—Rash—Diazepam—epilepsy syndrome	4.49e-05	0.000237	CcSEcCtD
Etodolac—Dermatitis—Diazepam—epilepsy syndrome	4.48e-05	0.000236	CcSEcCtD
Etodolac—Visual impairment—Topiramate—epilepsy syndrome	4.48e-05	0.000236	CcSEcCtD
Etodolac—Arthralgia—Pregabalin—epilepsy syndrome	4.46e-05	0.000235	CcSEcCtD
Etodolac—Myalgia—Pregabalin—epilepsy syndrome	4.46e-05	0.000235	CcSEcCtD
Etodolac—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.46e-05	0.000235	CcSEcCtD
Etodolac—Dizziness—Zonisamide—epilepsy syndrome	4.46e-05	0.000235	CcSEcCtD
Etodolac—Headache—Diazepam—epilepsy syndrome	4.46e-05	0.000235	CcSEcCtD
Etodolac—Anxiety—Pregabalin—epilepsy syndrome	4.45e-05	0.000234	CcSEcCtD
Etodolac—Diarrhoea—Clonazepam—epilepsy syndrome	4.45e-05	0.000234	CcSEcCtD
Etodolac—Anaemia—Gabapentin—epilepsy syndrome	4.44e-05	0.000234	CcSEcCtD
Etodolac—Hypotension—Valproic Acid—epilepsy syndrome	4.42e-05	0.000233	CcSEcCtD
Etodolac—Asthenia—Carbamazepine—epilepsy syndrome	4.42e-05	0.000233	CcSEcCtD
Etodolac—Diarrhoea—Phenytoin—epilepsy syndrome	4.42e-05	0.000233	CcSEcCtD
Etodolac—Discomfort—Pregabalin—epilepsy syndrome	4.41e-05	0.000232	CcSEcCtD
Etodolac—Nausea—Fosphenytoin—epilepsy syndrome	4.4e-05	0.000232	CcSEcCtD
Etodolac—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.39e-05	0.000232	CcSEcCtD
Etodolac—Erythema multiforme—Topiramate—epilepsy syndrome	4.39e-05	0.000231	CcSEcCtD
Etodolac—Angioedema—Gabapentin—epilepsy syndrome	4.39e-05	0.000231	CcSEcCtD
Etodolac—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.39e-05	0.000231	CcSEcCtD
Etodolac—Vomiting—Felbamate—epilepsy syndrome	4.38e-05	0.000231	CcSEcCtD
Etodolac—Dry mouth—Pregabalin—epilepsy syndrome	4.36e-05	0.00023	CcSEcCtD
Etodolac—Pruritus—Carbamazepine—epilepsy syndrome	4.36e-05	0.00023	CcSEcCtD
Etodolac—Rash—Felbamate—epilepsy syndrome	4.34e-05	0.000229	CcSEcCtD
Etodolac—Dermatitis—Felbamate—epilepsy syndrome	4.34e-05	0.000229	CcSEcCtD
Etodolac—Malaise—Gabapentin—epilepsy syndrome	4.33e-05	0.000228	CcSEcCtD
Etodolac—Tinnitus—Topiramate—epilepsy syndrome	4.33e-05	0.000228	CcSEcCtD
Etodolac—Vertigo—Gabapentin—epilepsy syndrome	4.32e-05	0.000228	CcSEcCtD
Etodolac—Headache—Felbamate—epilepsy syndrome	4.31e-05	0.000227	CcSEcCtD
Etodolac—Confusional state—Pregabalin—epilepsy syndrome	4.31e-05	0.000227	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.31e-05	0.000227	CcSEcCtD
Etodolac—Flushing—Topiramate—epilepsy syndrome	4.31e-05	0.000227	CcSEcCtD
Etodolac—Syncope—Gabapentin—epilepsy syndrome	4.31e-05	0.000227	CcSEcCtD
Etodolac—Leukopenia—Gabapentin—epilepsy syndrome	4.3e-05	0.000227	CcSEcCtD
Etodolac—Dizziness—Clonazepam—epilepsy syndrome	4.3e-05	0.000226	CcSEcCtD
Etodolac—Nausea—Vigabatrin—epilepsy syndrome	4.29e-05	0.000226	CcSEcCtD
Etodolac—Vomiting—Zonisamide—epilepsy syndrome	4.29e-05	0.000226	CcSEcCtD
Etodolac—Insomnia—Valproic Acid—epilepsy syndrome	4.28e-05	0.000226	CcSEcCtD
Etodolac—Oedema—Pregabalin—epilepsy syndrome	4.28e-05	0.000225	CcSEcCtD
Etodolac—Anaphylactic shock—Pregabalin—epilepsy syndrome	4.28e-05	0.000225	CcSEcCtD
Etodolac—Asthenia—Lamotrigine—epilepsy syndrome	4.27e-05	0.000225	CcSEcCtD
Etodolac—Dizziness—Phenytoin—epilepsy syndrome	4.27e-05	0.000225	CcSEcCtD
Etodolac—Rash—Zonisamide—epilepsy syndrome	4.25e-05	0.000224	CcSEcCtD
Etodolac—Infection—Pregabalin—epilepsy syndrome	4.25e-05	0.000224	CcSEcCtD
Etodolac—Paraesthesia—Valproic Acid—epilepsy syndrome	4.25e-05	0.000224	CcSEcCtD
Etodolac—Palpitations—Gabapentin—epilepsy syndrome	4.25e-05	0.000224	CcSEcCtD
Etodolac—Dermatitis—Zonisamide—epilepsy syndrome	4.25e-05	0.000224	CcSEcCtD
Etodolac—Dizziness—Oxcarbazepine—epilepsy syndrome	4.25e-05	0.000224	CcSEcCtD
Etodolac—Nausea—Diazepam—epilepsy syndrome	4.23e-05	0.000223	CcSEcCtD
Etodolac—Loss of consciousness—Gabapentin—epilepsy syndrome	4.22e-05	0.000223	CcSEcCtD
Etodolac—Headache—Zonisamide—epilepsy syndrome	4.22e-05	0.000223	CcSEcCtD
Etodolac—Dyspnoea—Valproic Acid—epilepsy syndrome	4.22e-05	0.000222	CcSEcCtD
Etodolac—Diarrhoea—Carbamazepine—epilepsy syndrome	4.22e-05	0.000222	CcSEcCtD
Etodolac—Pruritus—Lamotrigine—epilepsy syndrome	4.21e-05	0.000222	CcSEcCtD
Etodolac—Shock—Pregabalin—epilepsy syndrome	4.21e-05	0.000222	CcSEcCtD
Etodolac—Somnolence—Valproic Acid—epilepsy syndrome	4.21e-05	0.000222	CcSEcCtD
Etodolac—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.19e-05	0.000221	CcSEcCtD
Etodolac—Tachycardia—Pregabalin—epilepsy syndrome	4.17e-05	0.00022	CcSEcCtD
Etodolac—Chills—Topiramate—epilepsy syndrome	4.17e-05	0.00022	CcSEcCtD
Etodolac—Dyspepsia—Valproic Acid—epilepsy syndrome	4.16e-05	0.00022	CcSEcCtD
Etodolac—Convulsion—Gabapentin—epilepsy syndrome	4.16e-05	0.000219	CcSEcCtD
Etodolac—Hypertension—Gabapentin—epilepsy syndrome	4.15e-05	0.000219	CcSEcCtD
Etodolac—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.14e-05	0.000218	CcSEcCtD
Etodolac—Vomiting—Clonazepam—epilepsy syndrome	4.13e-05	0.000218	CcSEcCtD
Etodolac—Decreased appetite—Valproic Acid—epilepsy syndrome	4.11e-05	0.000217	CcSEcCtD
Etodolac—Alopecia—Topiramate—epilepsy syndrome	4.1e-05	0.000216	CcSEcCtD
Etodolac—Vomiting—Phenytoin—epilepsy syndrome	4.1e-05	0.000216	CcSEcCtD
Etodolac—Rash—Clonazepam—epilepsy syndrome	4.1e-05	0.000216	CcSEcCtD
Etodolac—Dermatitis—Clonazepam—epilepsy syndrome	4.09e-05	0.000216	CcSEcCtD
Etodolac—Myalgia—Gabapentin—epilepsy syndrome	4.09e-05	0.000216	CcSEcCtD
Etodolac—Arthralgia—Gabapentin—epilepsy syndrome	4.09e-05	0.000216	CcSEcCtD
Etodolac—Nausea—Felbamate—epilepsy syndrome	4.09e-05	0.000216	CcSEcCtD
Etodolac—Vomiting—Oxcarbazepine—epilepsy syndrome	4.08e-05	0.000215	CcSEcCtD
Etodolac—Fatigue—Valproic Acid—epilepsy syndrome	4.08e-05	0.000215	CcSEcCtD
Etodolac—Anxiety—Gabapentin—epilepsy syndrome	4.08e-05	0.000215	CcSEcCtD
Etodolac—Anorexia—Pregabalin—epilepsy syndrome	4.08e-05	0.000215	CcSEcCtD
Etodolac—Dizziness—Carbamazepine—epilepsy syndrome	4.07e-05	0.000215	CcSEcCtD
Etodolac—Diarrhoea—Lamotrigine—epilepsy syndrome	4.07e-05	0.000215	CcSEcCtD
Etodolac—Headache—Clonazepam—epilepsy syndrome	4.07e-05	0.000215	CcSEcCtD
Etodolac—Rash—Phenytoin—epilepsy syndrome	4.07e-05	0.000214	CcSEcCtD
Etodolac—Dermatitis—Phenytoin—epilepsy syndrome	4.07e-05	0.000214	CcSEcCtD
Etodolac—Rash—Oxcarbazepine—epilepsy syndrome	4.05e-05	0.000213	CcSEcCtD
Etodolac—Pain—Valproic Acid—epilepsy syndrome	4.05e-05	0.000213	CcSEcCtD
Etodolac—Constipation—Valproic Acid—epilepsy syndrome	4.05e-05	0.000213	CcSEcCtD
Etodolac—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.04e-05	0.000213	CcSEcCtD
Etodolac—Headache—Phenytoin—epilepsy syndrome	4.04e-05	0.000213	CcSEcCtD
Etodolac—Discomfort—Gabapentin—epilepsy syndrome	4.04e-05	0.000213	CcSEcCtD
Etodolac—Headache—Oxcarbazepine—epilepsy syndrome	4.02e-05	0.000212	CcSEcCtD
Etodolac—Nausea—Zonisamide—epilepsy syndrome	4e-05	0.000211	CcSEcCtD
Etodolac—Dry mouth—Gabapentin—epilepsy syndrome	4e-05	0.000211	CcSEcCtD
Etodolac—Hypotension—Pregabalin—epilepsy syndrome	4e-05	0.000211	CcSEcCtD
Etodolac—Flatulence—Topiramate—epilepsy syndrome	3.98e-05	0.00021	CcSEcCtD
Etodolac—Tension—Topiramate—epilepsy syndrome	3.97e-05	0.000209	CcSEcCtD
Etodolac—Dysgeusia—Topiramate—epilepsy syndrome	3.96e-05	0.000209	CcSEcCtD
Etodolac—Confusional state—Gabapentin—epilepsy syndrome	3.95e-05	0.000208	CcSEcCtD
Etodolac—Dizziness—Lamotrigine—epilepsy syndrome	3.94e-05	0.000208	CcSEcCtD
Etodolac—Nervousness—Topiramate—epilepsy syndrome	3.93e-05	0.000207	CcSEcCtD
Etodolac—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.92e-05	0.000207	CcSEcCtD
Etodolac—Oedema—Gabapentin—epilepsy syndrome	3.92e-05	0.000207	CcSEcCtD
Etodolac—Vomiting—Carbamazepine—epilepsy syndrome	3.92e-05	0.000206	CcSEcCtD
Etodolac—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.9e-05	0.000206	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.9e-05	0.000205	CcSEcCtD
Etodolac—Infection—Gabapentin—epilepsy syndrome	3.9e-05	0.000205	CcSEcCtD
Etodolac—Rash—Carbamazepine—epilepsy syndrome	3.88e-05	0.000205	CcSEcCtD
Etodolac—Dermatitis—Carbamazepine—epilepsy syndrome	3.88e-05	0.000205	CcSEcCtD
Etodolac—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.87e-05	0.000204	CcSEcCtD
Etodolac—Insomnia—Pregabalin—epilepsy syndrome	3.87e-05	0.000204	CcSEcCtD
Etodolac—Nausea—Clonazepam—epilepsy syndrome	3.86e-05	0.000203	CcSEcCtD
Etodolac—Headache—Carbamazepine—epilepsy syndrome	3.86e-05	0.000203	CcSEcCtD
Etodolac—Shock—Gabapentin—epilepsy syndrome	3.86e-05	0.000203	CcSEcCtD
Etodolac—Paraesthesia—Pregabalin—epilepsy syndrome	3.84e-05	0.000202	CcSEcCtD
Etodolac—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.84e-05	0.000202	CcSEcCtD
Etodolac—Nausea—Phenytoin—epilepsy syndrome	3.83e-05	0.000202	CcSEcCtD
Etodolac—Tachycardia—Gabapentin—epilepsy syndrome	3.83e-05	0.000202	CcSEcCtD
Etodolac—Dyspnoea—Pregabalin—epilepsy syndrome	3.81e-05	0.000201	CcSEcCtD
Etodolac—Nausea—Oxcarbazepine—epilepsy syndrome	3.81e-05	0.000201	CcSEcCtD
Etodolac—Vision blurred—Topiramate—epilepsy syndrome	3.81e-05	0.000201	CcSEcCtD
Etodolac—Somnolence—Pregabalin—epilepsy syndrome	3.8e-05	0.0002	CcSEcCtD
Etodolac—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.79e-05	0.0002	CcSEcCtD
Etodolac—Tremor—Topiramate—epilepsy syndrome	3.79e-05	0.0002	CcSEcCtD
Etodolac—Vomiting—Lamotrigine—epilepsy syndrome	3.79e-05	0.0002	CcSEcCtD
Etodolac—Urticaria—Valproic Acid—epilepsy syndrome	3.76e-05	0.000198	CcSEcCtD
Etodolac—Rash—Lamotrigine—epilepsy syndrome	3.75e-05	0.000198	CcSEcCtD
Etodolac—Ill-defined disorder—Topiramate—epilepsy syndrome	3.75e-05	0.000198	CcSEcCtD
Etodolac—Dermatitis—Lamotrigine—epilepsy syndrome	3.75e-05	0.000198	CcSEcCtD
Etodolac—Abdominal pain—Valproic Acid—epilepsy syndrome	3.74e-05	0.000197	CcSEcCtD
Etodolac—Body temperature increased—Valproic Acid—epilepsy syndrome	3.74e-05	0.000197	CcSEcCtD
Etodolac—Anorexia—Gabapentin—epilepsy syndrome	3.74e-05	0.000197	CcSEcCtD
Etodolac—Anaemia—Topiramate—epilepsy syndrome	3.74e-05	0.000197	CcSEcCtD
Etodolac—Headache—Lamotrigine—epilepsy syndrome	3.73e-05	0.000197	CcSEcCtD
Etodolac—Decreased appetite—Pregabalin—epilepsy syndrome	3.72e-05	0.000196	CcSEcCtD
Etodolac—Fatigue—Pregabalin—epilepsy syndrome	3.69e-05	0.000194	CcSEcCtD
Etodolac—Hypotension—Gabapentin—epilepsy syndrome	3.67e-05	0.000193	CcSEcCtD
Etodolac—Nausea—Carbamazepine—epilepsy syndrome	3.66e-05	0.000193	CcSEcCtD
Etodolac—Pain—Pregabalin—epilepsy syndrome	3.66e-05	0.000193	CcSEcCtD
Etodolac—Constipation—Pregabalin—epilepsy syndrome	3.66e-05	0.000193	CcSEcCtD
Etodolac—Malaise—Topiramate—epilepsy syndrome	3.65e-05	0.000192	CcSEcCtD
Etodolac—Vertigo—Topiramate—epilepsy syndrome	3.63e-05	0.000191	CcSEcCtD
Etodolac—Syncope—Topiramate—epilepsy syndrome	3.63e-05	0.000191	CcSEcCtD
Etodolac—Leukopenia—Topiramate—epilepsy syndrome	3.62e-05	0.000191	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.57e-05	0.000188	CcSEcCtD
Etodolac—Palpitations—Topiramate—epilepsy syndrome	3.57e-05	0.000188	CcSEcCtD
Etodolac—Loss of consciousness—Topiramate—epilepsy syndrome	3.55e-05	0.000187	CcSEcCtD
Etodolac—Insomnia—Gabapentin—epilepsy syndrome	3.55e-05	0.000187	CcSEcCtD
Etodolac—Nausea—Lamotrigine—epilepsy syndrome	3.54e-05	0.000186	CcSEcCtD
Etodolac—Feeling abnormal—Pregabalin—epilepsy syndrome	3.52e-05	0.000186	CcSEcCtD
Etodolac—Paraesthesia—Gabapentin—epilepsy syndrome	3.52e-05	0.000186	CcSEcCtD
Etodolac—Convulsion—Topiramate—epilepsy syndrome	3.5e-05	0.000185	CcSEcCtD
Etodolac—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.5e-05	0.000184	CcSEcCtD
Etodolac—Dyspnoea—Gabapentin—epilepsy syndrome	3.5e-05	0.000184	CcSEcCtD
Etodolac—Hypertension—Topiramate—epilepsy syndrome	3.49e-05	0.000184	CcSEcCtD
Etodolac—Somnolence—Gabapentin—epilepsy syndrome	3.49e-05	0.000184	CcSEcCtD
Etodolac—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.49e-05	0.000184	CcSEcCtD
Etodolac—Dyspepsia—Gabapentin—epilepsy syndrome	3.45e-05	0.000182	CcSEcCtD
Etodolac—Myalgia—Topiramate—epilepsy syndrome	3.44e-05	0.000181	CcSEcCtD
Etodolac—Arthralgia—Topiramate—epilepsy syndrome	3.44e-05	0.000181	CcSEcCtD
Etodolac—Anxiety—Topiramate—epilepsy syndrome	3.43e-05	0.000181	CcSEcCtD
Etodolac—Decreased appetite—Gabapentin—epilepsy syndrome	3.41e-05	0.00018	CcSEcCtD
Etodolac—Discomfort—Topiramate—epilepsy syndrome	3.4e-05	0.000179	CcSEcCtD
Etodolac—Urticaria—Pregabalin—epilepsy syndrome	3.4e-05	0.000179	CcSEcCtD
Etodolac—Asthenia—Valproic Acid—epilepsy syndrome	3.39e-05	0.000179	CcSEcCtD
Etodolac—Fatigue—Gabapentin—epilepsy syndrome	3.38e-05	0.000178	CcSEcCtD
Etodolac—Body temperature increased—Pregabalin—epilepsy syndrome	3.38e-05	0.000178	CcSEcCtD
Etodolac—Abdominal pain—Pregabalin—epilepsy syndrome	3.38e-05	0.000178	CcSEcCtD
Etodolac—Dry mouth—Topiramate—epilepsy syndrome	3.37e-05	0.000177	CcSEcCtD
Etodolac—Pain—Gabapentin—epilepsy syndrome	3.35e-05	0.000177	CcSEcCtD
Etodolac—Constipation—Gabapentin—epilepsy syndrome	3.35e-05	0.000177	CcSEcCtD
Etodolac—Pruritus—Valproic Acid—epilepsy syndrome	3.35e-05	0.000176	CcSEcCtD
Etodolac—Confusional state—Topiramate—epilepsy syndrome	3.33e-05	0.000175	CcSEcCtD
Etodolac—Oedema—Topiramate—epilepsy syndrome	3.3e-05	0.000174	CcSEcCtD
Etodolac—Infection—Topiramate—epilepsy syndrome	3.28e-05	0.000173	CcSEcCtD
Etodolac—Shock—Topiramate—epilepsy syndrome	3.25e-05	0.000171	CcSEcCtD
Etodolac—Diarrhoea—Valproic Acid—epilepsy syndrome	3.24e-05	0.000171	CcSEcCtD
Etodolac—Feeling abnormal—Gabapentin—epilepsy syndrome	3.23e-05	0.00017	CcSEcCtD
Etodolac—Thrombocytopenia—Topiramate—epilepsy syndrome	3.23e-05	0.00017	CcSEcCtD
Etodolac—Tachycardia—Topiramate—epilepsy syndrome	3.22e-05	0.00017	CcSEcCtD
Etodolac—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.21e-05	0.000169	CcSEcCtD
Etodolac—Hyperhidrosis—Topiramate—epilepsy syndrome	3.19e-05	0.000168	CcSEcCtD
Etodolac—Hypersensitivity—Pregabalin—epilepsy syndrome	3.15e-05	0.000166	CcSEcCtD
Etodolac—Anorexia—Topiramate—epilepsy syndrome	3.15e-05	0.000166	CcSEcCtD
Etodolac—Dizziness—Valproic Acid—epilepsy syndrome	3.13e-05	0.000165	CcSEcCtD
Etodolac—Urticaria—Gabapentin—epilepsy syndrome	3.12e-05	0.000164	CcSEcCtD
Etodolac—Body temperature increased—Gabapentin—epilepsy syndrome	3.1e-05	0.000163	CcSEcCtD
Etodolac—Abdominal pain—Gabapentin—epilepsy syndrome	3.1e-05	0.000163	CcSEcCtD
Etodolac—Hypotension—Topiramate—epilepsy syndrome	3.08e-05	0.000163	CcSEcCtD
Etodolac—Asthenia—Pregabalin—epilepsy syndrome	3.07e-05	0.000162	CcSEcCtD
Etodolac—Pruritus—Pregabalin—epilepsy syndrome	3.03e-05	0.00016	CcSEcCtD
Etodolac—Vomiting—Valproic Acid—epilepsy syndrome	3.01e-05	0.000159	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.01e-05	0.000158	CcSEcCtD
Etodolac—Insomnia—Topiramate—epilepsy syndrome	2.98e-05	0.000157	CcSEcCtD
Etodolac—Rash—Valproic Acid—epilepsy syndrome	2.98e-05	0.000157	CcSEcCtD
Etodolac—Dermatitis—Valproic Acid—epilepsy syndrome	2.98e-05	0.000157	CcSEcCtD
Etodolac—Headache—Valproic Acid—epilepsy syndrome	2.96e-05	0.000156	CcSEcCtD
Etodolac—Paraesthesia—Topiramate—epilepsy syndrome	2.96e-05	0.000156	CcSEcCtD
Etodolac—Dyspnoea—Topiramate—epilepsy syndrome	2.94e-05	0.000155	CcSEcCtD
Etodolac—Somnolence—Topiramate—epilepsy syndrome	2.93e-05	0.000155	CcSEcCtD
Etodolac—Diarrhoea—Pregabalin—epilepsy syndrome	2.93e-05	0.000154	CcSEcCtD
Etodolac—Dyspepsia—Topiramate—epilepsy syndrome	2.9e-05	0.000153	CcSEcCtD
Etodolac—Hypersensitivity—Gabapentin—epilepsy syndrome	2.89e-05	0.000152	CcSEcCtD
Etodolac—Decreased appetite—Topiramate—epilepsy syndrome	2.87e-05	0.000151	CcSEcCtD
Etodolac—Fatigue—Topiramate—epilepsy syndrome	2.84e-05	0.00015	CcSEcCtD
Etodolac—Dizziness—Pregabalin—epilepsy syndrome	2.83e-05	0.000149	CcSEcCtD
Etodolac—Pain—Topiramate—epilepsy syndrome	2.82e-05	0.000149	CcSEcCtD
Etodolac—Constipation—Topiramate—epilepsy syndrome	2.82e-05	0.000149	CcSEcCtD
Etodolac—Asthenia—Gabapentin—epilepsy syndrome	2.81e-05	0.000148	CcSEcCtD
Etodolac—Nausea—Valproic Acid—epilepsy syndrome	2.81e-05	0.000148	CcSEcCtD
Etodolac—Pruritus—Gabapentin—epilepsy syndrome	2.77e-05	0.000146	CcSEcCtD
Etodolac—Vomiting—Pregabalin—epilepsy syndrome	2.72e-05	0.000143	CcSEcCtD
Etodolac—Feeling abnormal—Topiramate—epilepsy syndrome	2.72e-05	0.000143	CcSEcCtD
Etodolac—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.7e-05	0.000142	CcSEcCtD
Etodolac—Rash—Pregabalin—epilepsy syndrome	2.7e-05	0.000142	CcSEcCtD
Etodolac—Dermatitis—Pregabalin—epilepsy syndrome	2.69e-05	0.000142	CcSEcCtD
Etodolac—Diarrhoea—Gabapentin—epilepsy syndrome	2.68e-05	0.000141	CcSEcCtD
Etodolac—Headache—Pregabalin—epilepsy syndrome	2.68e-05	0.000141	CcSEcCtD
Etodolac—Urticaria—Topiramate—epilepsy syndrome	2.62e-05	0.000138	CcSEcCtD
Etodolac—Abdominal pain—Topiramate—epilepsy syndrome	2.61e-05	0.000137	CcSEcCtD
Etodolac—Body temperature increased—Topiramate—epilepsy syndrome	2.61e-05	0.000137	CcSEcCtD
Etodolac—Dizziness—Gabapentin—epilepsy syndrome	2.59e-05	0.000137	CcSEcCtD
Etodolac—Nausea—Pregabalin—epilepsy syndrome	2.54e-05	0.000134	CcSEcCtD
Etodolac—Vomiting—Gabapentin—epilepsy syndrome	2.49e-05	0.000131	CcSEcCtD
Etodolac—Rash—Gabapentin—epilepsy syndrome	2.47e-05	0.00013	CcSEcCtD
Etodolac—Dermatitis—Gabapentin—epilepsy syndrome	2.47e-05	0.00013	CcSEcCtD
Etodolac—Headache—Gabapentin—epilepsy syndrome	2.46e-05	0.00013	CcSEcCtD
Etodolac—Hypersensitivity—Topiramate—epilepsy syndrome	2.43e-05	0.000128	CcSEcCtD
Etodolac—Asthenia—Topiramate—epilepsy syndrome	2.37e-05	0.000125	CcSEcCtD
Etodolac—Pruritus—Topiramate—epilepsy syndrome	2.33e-05	0.000123	CcSEcCtD
Etodolac—Nausea—Gabapentin—epilepsy syndrome	2.33e-05	0.000123	CcSEcCtD
Etodolac—Diarrhoea—Topiramate—epilepsy syndrome	2.26e-05	0.000119	CcSEcCtD
Etodolac—Dizziness—Topiramate—epilepsy syndrome	2.18e-05	0.000115	CcSEcCtD
Etodolac—Vomiting—Topiramate—epilepsy syndrome	2.1e-05	0.000111	CcSEcCtD
Etodolac—Rash—Topiramate—epilepsy syndrome	2.08e-05	0.00011	CcSEcCtD
Etodolac—Dermatitis—Topiramate—epilepsy syndrome	2.08e-05	0.00011	CcSEcCtD
Etodolac—Headache—Topiramate—epilepsy syndrome	2.07e-05	0.000109	CcSEcCtD
Etodolac—Nausea—Topiramate—epilepsy syndrome	1.96e-05	0.000103	CcSEcCtD
Etodolac—CYP2C9—Metabolism—PFKL—epilepsy syndrome	9.7e-06	0.000137	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	9.7e-06	0.000137	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—TH—epilepsy syndrome	9.69e-06	0.000137	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—ALB—epilepsy syndrome	9.67e-06	0.000136	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ADRA2A—epilepsy syndrome	9.65e-06	0.000136	CbGpPWpGaD
Etodolac—RXRA—Metabolism—BCHE—epilepsy syndrome	9.61e-06	0.000135	CbGpPWpGaD
Etodolac—ALB—Hemostasis—AKT3—epilepsy syndrome	9.52e-06	0.000134	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—HMOX1—epilepsy syndrome	9.51e-06	0.000134	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	9.48e-06	0.000134	CbGpPWpGaD
Etodolac—ALB—Metabolism—ASAH1—epilepsy syndrome	9.47e-06	0.000133	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	9.46e-06	0.000133	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—SIRT1—epilepsy syndrome	9.43e-06	0.000133	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	9.42e-06	0.000133	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	9.41e-06	0.000133	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PLAUR—epilepsy syndrome	9.41e-06	0.000133	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CAT—epilepsy syndrome	9.38e-06	0.000132	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	9.36e-06	0.000132	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—VDR—epilepsy syndrome	9.29e-06	0.000131	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	9.22e-06	0.00013	CbGpPWpGaD
Etodolac—ALB—Metabolism—STXBP1—epilepsy syndrome	9.21e-06	0.00013	CbGpPWpGaD
Etodolac—RXRA—Metabolism—SLC2A1—epilepsy syndrome	9.17e-06	0.000129	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	9.14e-06	0.000129	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—ABCB1—epilepsy syndrome	9.13e-06	0.000129	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PLCB1—epilepsy syndrome	9.07e-06	0.000128	CbGpPWpGaD
Etodolac—RXRA—Metabolism—TH—epilepsy syndrome	9.04e-06	0.000127	CbGpPWpGaD
Etodolac—PTGS2—Disease—EIF2AK2—epilepsy syndrome	9.01e-06	0.000127	CbGpPWpGaD
Etodolac—ALB—Metabolism—NT5E—epilepsy syndrome	8.98e-06	0.000127	CbGpPWpGaD
Etodolac—ALB—Metabolism—ALAD—epilepsy syndrome	8.98e-06	0.000127	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	8.93e-06	0.000126	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.9e-06	0.000125	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AQP1—epilepsy syndrome	8.87e-06	0.000125	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—UPB1—epilepsy syndrome	8.87e-06	0.000125	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ATIC—epilepsy syndrome	8.87e-06	0.000125	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NEU1—epilepsy syndrome	8.87e-06	0.000125	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.86e-06	0.000125	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CYP2D6—epilepsy syndrome	8.83e-06	0.000124	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—H2AFX—epilepsy syndrome	8.81e-06	0.000124	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MMP9—epilepsy syndrome	8.74e-06	0.000123	CbGpPWpGaD
Etodolac—ALB—Hemostasis—CDC42—epilepsy syndrome	8.69e-06	0.000122	CbGpPWpGaD
Etodolac—ALB—Metabolism—ALDH7A1—epilepsy syndrome	8.56e-06	0.000121	CbGpPWpGaD
Etodolac—ALB—Metabolism—CACNA1A—epilepsy syndrome	8.56e-06	0.000121	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	8.54e-06	0.00012	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	8.52e-06	0.00012	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—YWHAZ—epilepsy syndrome	8.5e-06	0.00012	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GPX1—epilepsy syndrome	8.49e-06	0.00012	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	8.48e-06	0.00012	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ADRA2A—epilepsy syndrome	8.41e-06	0.000119	CbGpPWpGaD
Etodolac—ALB—Metabolism—ST3GAL3—epilepsy syndrome	8.38e-06	0.000118	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—BCHE—epilepsy syndrome	8.37e-06	0.000118	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—NR3C1—epilepsy syndrome	8.36e-06	0.000118	CbGpPWpGaD
Etodolac—PTGS2—Disease—PPIA—epilepsy syndrome	8.33e-06	0.000117	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	8.24e-06	0.000116	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GBE1—epilepsy syndrome	8.24e-06	0.000116	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ABCG2—epilepsy syndrome	8.24e-06	0.000116	CbGpPWpGaD
Etodolac—ALB—Metabolism—ADSL—epilepsy syndrome	8.21e-06	0.000116	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	8.11e-06	0.000114	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—HMOX1—epilepsy syndrome	8.09e-06	0.000114	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	8.06e-06	0.000114	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—SRC—epilepsy syndrome	8.06e-06	0.000114	CbGpPWpGaD
Etodolac—ALB—Metabolism—GLUL—epilepsy syndrome	8.05e-06	0.000113	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP2C19—epilepsy syndrome	8.03e-06	0.000113	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CHRM3—epilepsy syndrome	8.02e-06	0.000113	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	8.02e-06	0.000113	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—SLC2A1—epilepsy syndrome	7.99e-06	0.000113	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP11A1—epilepsy syndrome	7.98e-06	0.000112	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CAT—epilepsy syndrome	7.98e-06	0.000112	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	7.92e-06	0.000112	CbGpPWpGaD
Etodolac—ALB—Metabolism—CACNA1D—epilepsy syndrome	7.9e-06	0.000111	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PLCB1—epilepsy syndrome	7.9e-06	0.000111	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—TH—epilepsy syndrome	7.87e-06	0.000111	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—VEGFA—epilepsy syndrome	7.85e-06	0.000111	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—ABCB1—epilepsy syndrome	7.76e-06	0.000109	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	7.75e-06	0.000109	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.75e-06	0.000109	CbGpPWpGaD
Etodolac—ALB—Hemostasis—FYN—epilepsy syndrome	7.73e-06	0.000109	CbGpPWpGaD
Etodolac—RXRA—Metabolism—HMOX1—epilepsy syndrome	7.54e-06	0.000106	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	7.54e-06	0.000106	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.47e-06	0.000105	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CAT—epilepsy syndrome	7.44e-06	0.000105	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—AGT—epilepsy syndrome	7.44e-06	0.000105	CbGpPWpGaD
Etodolac—ALB—Hemostasis—YWHAZ—epilepsy syndrome	7.43e-06	0.000105	CbGpPWpGaD
Etodolac—ALB—Metabolism—TXNRD1—epilepsy syndrome	7.39e-06	0.000104	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALAD—epilepsy syndrome	7.35e-06	0.000104	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NT5E—epilepsy syndrome	7.35e-06	0.000104	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	7.34e-06	0.000104	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.32e-06	0.000103	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—APOE—epilepsy syndrome	7.29e-06	0.000103	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	7.28e-06	0.000103	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ABCB1—epilepsy syndrome	7.24e-06	0.000102	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.22e-06	0.000102	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GPX1—epilepsy syndrome	7.22e-06	0.000102	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP2D6—epilepsy syndrome	7.2e-06	0.000101	CbGpPWpGaD
Etodolac—ALB—Metabolism—AQP1—epilepsy syndrome	7.18e-06	0.000101	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	7.05e-06	9.94e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	7.01e-06	9.88e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	7.01e-06	9.88e-05	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	6.99e-06	9.86e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.89e-06	9.71e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	6.86e-06	9.67e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	6.85e-06	9.66e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—BCHE—epilepsy syndrome	6.83e-06	9.62e-05	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	6.81e-06	9.6e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GPX1—epilepsy syndrome	6.73e-06	9.49e-05	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TNF—epilepsy syndrome	6.73e-06	9.48e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ADSL—epilepsy syndrome	6.72e-06	9.47e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PLAU—epilepsy syndrome	6.6e-06	9.3e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GLUL—epilepsy syndrome	6.59e-06	9.29e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—HMOX1—epilepsy syndrome	6.57e-06	9.26e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ABCG2—epilepsy syndrome	6.54e-06	9.22e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	6.51e-06	9.18e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CHRM3—epilepsy syndrome	6.49e-06	9.15e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—KCNJ11—epilepsy syndrome	6.49e-06	9.15e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CAT—epilepsy syndrome	6.48e-06	9.14e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	6.47e-06	9.12e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PLCB1—epilepsy syndrome	6.44e-06	9.08e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—TH—epilepsy syndrome	6.42e-06	9.04e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	6.37e-06	8.98e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	6.33e-06	8.93e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—AGT—epilepsy syndrome	6.33e-06	8.92e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.32e-06	8.9e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ABCB1—epilepsy syndrome	6.31e-06	8.89e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.29e-06	8.86e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—POMC—epilepsy syndrome	6.26e-06	8.83e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—APOE—epilepsy syndrome	6.2e-06	8.74e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—SLC2A1—epilepsy syndrome	6.17e-06	8.7e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PRKCB—epilepsy syndrome	6.13e-06	8.65e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—JUNB—epilepsy syndrome	6.13e-06	8.64e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—NOS1—epilepsy syndrome	6.08e-06	8.57e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—NOS2—epilepsy syndrome	6.06e-06	8.54e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	6.05e-06	8.53e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.04e-06	8.52e-05	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	6.04e-06	8.51e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.92e-06	8.35e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—AGT—epilepsy syndrome	5.9e-06	8.32e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AQP1—epilepsy syndrome	5.87e-06	8.28e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GPX1—epilepsy syndrome	5.86e-06	8.26e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—HBEGF—epilepsy syndrome	5.8e-06	8.18e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—APOE—epilepsy syndrome	5.78e-06	8.15e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.73e-06	8.08e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	5.72e-06	8.06e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—ALB—epilepsy syndrome	5.71e-06	8.05e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKT3—epilepsy syndrome	5.7e-06	8.03e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.64e-06	7.95e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—ADAM10—epilepsy syndrome	5.56e-06	7.84e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	5.44e-06	7.67e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—BCHE—epilepsy syndrome	5.42e-06	7.64e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—HMOX1—epilepsy syndrome	5.36e-06	7.55e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—POMC—epilepsy syndrome	5.33e-06	7.51e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	5.31e-06	7.49e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	5.31e-06	7.49e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ABCG2—epilepsy syndrome	5.29e-06	7.46e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CAT—epilepsy syndrome	5.28e-06	7.45e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CDC42—epilepsy syndrome	5.2e-06	7.33e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	5.17e-06	7.29e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP2C19—epilepsy syndrome	5.16e-06	7.27e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ABCB1—epilepsy syndrome	5.14e-06	7.25e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—AGT—epilepsy syndrome	5.14e-06	7.25e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP11A1—epilepsy syndrome	5.12e-06	7.22e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PLCB1—epilepsy syndrome	5.11e-06	7.21e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—TH—epilepsy syndrome	5.09e-06	7.18e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.09e-06	7.17e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—APOE—epilepsy syndrome	5.04e-06	7.1e-05	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—AKT1—epilepsy syndrome	5.01e-06	7.06e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTGS2—epilepsy syndrome	5e-06	7.04e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—POMC—epilepsy syndrome	4.97e-06	7e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.95e-06	6.97e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—ALB—epilepsy syndrome	4.86e-06	6.84e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.85e-06	6.83e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GPX1—epilepsy syndrome	4.78e-06	6.74e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—HES1—epilepsy syndrome	4.76e-06	6.71e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—FYN—epilepsy syndrome	4.63e-06	6.52e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP2D6—epilepsy syndrome	4.62e-06	6.52e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—H2AFX—epilepsy syndrome	4.61e-06	6.5e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ALB—epilepsy syndrome	4.53e-06	6.38e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—YWHAZ—epilepsy syndrome	4.45e-06	6.27e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ADRA2A—epilepsy syndrome	4.4e-06	6.2e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—BCHE—epilepsy syndrome	4.38e-06	6.18e-05	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	4.35e-06	6.12e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	4.33e-06	6.1e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—POMC—epilepsy syndrome	4.33e-06	6.1e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CCR5—epilepsy syndrome	4.28e-06	6.03e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—HMOX1—epilepsy syndrome	4.25e-06	5.99e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTGS2—epilepsy syndrome	4.25e-06	5.99e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	4.22e-06	5.95e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CAT—epilepsy syndrome	4.2e-06	5.91e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	4.19e-06	5.91e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AGT—epilepsy syndrome	4.19e-06	5.91e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—SLC2A1—epilepsy syndrome	4.18e-06	5.89e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.16e-06	5.87e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PLCB1—epilepsy syndrome	4.14e-06	5.83e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—TH—epilepsy syndrome	4.12e-06	5.81e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—APOE—epilepsy syndrome	4.11e-06	5.79e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ABCB1—epilepsy syndrome	4.08e-06	5.75e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.06e-06	5.72e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—TSC2—epilepsy syndrome	3.98e-06	5.61e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTGS2—epilepsy syndrome	3.96e-06	5.58e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ALB—epilepsy syndrome	3.95e-06	5.56e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—APOE—epilepsy syndrome	3.89e-06	5.49e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.8e-06	5.35e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GPX1—epilepsy syndrome	3.79e-06	5.35e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	3.79e-06	5.33e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—IL6ST—epilepsy syndrome	3.66e-06	5.15e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—NOS2—epilepsy syndrome	3.63e-06	5.11e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—SRC—epilepsy syndrome	3.6e-06	5.08e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	3.6e-06	5.08e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—BCHE—epilepsy syndrome	3.59e-06	5.06e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—POMC—epilepsy syndrome	3.53e-06	4.97e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—VEGFA—epilepsy syndrome	3.51e-06	4.95e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTGS2—epilepsy syndrome	3.45e-06	4.86e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—HMOX1—epilepsy syndrome	3.44e-06	4.85e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	3.42e-06	4.82e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CAT—epilepsy syndrome	3.39e-06	4.78e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	3.39e-06	4.77e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—TH—epilepsy syndrome	3.37e-06	4.75e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AGT—epilepsy syndrome	3.33e-06	4.69e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.32e-06	4.68e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ABCB1—epilepsy syndrome	3.3e-06	4.65e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—APOE—epilepsy syndrome	3.26e-06	4.59e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ALB—epilepsy syndrome	3.22e-06	4.53e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GPX1—epilepsy syndrome	3.07e-06	4.33e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—FGF2—epilepsy syndrome	2.96e-06	4.17e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.82e-06	3.97e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTGS2—epilepsy syndrome	2.81e-06	3.97e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—POMC—epilepsy syndrome	2.8e-06	3.95e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.78e-06	3.92e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.7e-06	3.81e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MTOR—epilepsy syndrome	2.69e-06	3.79e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—AGT—epilepsy syndrome	2.69e-06	3.79e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—APOE—epilepsy syndrome	2.64e-06	3.72e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—AKT1—epilepsy syndrome	2.56e-06	3.61e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ALB—epilepsy syndrome	2.55e-06	3.6e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.51e-06	3.54e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—AKT1—epilepsy syndrome	2.51e-06	3.54e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—POMC—epilepsy syndrome	2.27e-06	3.19e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—AKT1—epilepsy syndrome	2.24e-06	3.16e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.2e-06	3.11e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.16e-06	3.04e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—SRC—epilepsy syndrome	2.16e-06	3.04e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—AKT1—epilepsy syndrome	2.13e-06	3.01e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—AKT1—epilepsy syndrome	1.99e-06	2.81e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.85e-06	2.61e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTGS2—epilepsy syndrome	1.81e-06	2.55e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—AKT1—epilepsy syndrome	1.73e-06	2.44e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.69e-06	2.38e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.48e-06	2.08e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AKT1—epilepsy syndrome	1.41e-06	1.99e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKT1—epilepsy syndrome	1.34e-06	1.89e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AKT1—epilepsy syndrome	1.12e-06	1.58e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—AKT1—epilepsy syndrome	9.08e-07	1.28e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AKT1—epilepsy syndrome	7.43e-07	1.05e-05	CbGpPWpGaD
